share_log

奥本海默:维持Portage Biotech(PRTG.US)优于大市评级, 目标价由26.00美元调整至18.00美元。

Oppenheimer: maintain the Portage Biotech (PRTG.US) better than the market rating, with the target price adjusted to $18.00 from $26.00.

Zhitong Finance ·  Nov 30, 2022 20:00
Oppenheimer: maintain the Portage Biotech (PRTG.US) better than the market rating, with the target price adjusted to $18.00 from $26.00.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment